('ich', 80);('asd', 25);('eeg', 22);('ass', 18);('neurology', 12);('epilepsia', 12);('stroke', 11);('seizures', 10);('levetiracetam', 9);('asds', 8);('lyon', 7);('electrographic seizures', 7);('retrospective', 6);('pds', 6);('poor outcome', 6);('figure', 5);('lpds', 5);('early', 5);('long term outcome', 5);('clinical', 5);('incidence', 5);('j clin neurophysiol', 5);('functional outcome', 4);('mri', 4);('according', 4);('seizure', 4);('neurocrit care', 4);('epileptic', 4);('phenytoin', 4);('hospices civils', 3);('lyon france', 3);('acute phase', 3);('seizures us', 3);('electrographic', 3);('delayed', 3);('cave', 3);('heart associationamerican stroke', 3);('rct', 3);('lancet', 3);('epilepsy res', 3);('prospective', 3);('laurent derex', 2);('center department', 2);('sleep medicine respiratory disease croix rousse', 2);('email', 2);('harmful lead', 2);('acute symptomatic seizures', 2);('risk death', 2);('clinical outcome', 2);('seizure prophylaxis', 2);('peach', 2);('consent', 2);('international league', 2);('epilepsy ilae', 2);('late seizures', 2);('similar general recurrence risk', 2);('ilae', 2);('different risk factors', 2);('consecutive patients', 2);('underwent ceeg', 2);('convulsive', 2);('patients electrographic seizures', 2);('post stroke epilepsy', 2);('cla', 2);('peds', 2);('prospective study', 2);('new onset epilepsy', 2);('mental status', 2);('matter debate', 2);('battey', 2);('rcts', 2);('stroke organisation eso', 2);('status epilepticus', 2);('studies', 2);('antiseizure drugs intracerebral hemorrhage', 2);('antiseizure drugs', 2);('rate patients', 2);('epilepsy', 2);('intracerebral hemorrhage', 2);('j neurol neurosurg psychiatry', 2);('eur stroke j', 2);('arch neurol', 2);('predictors', 2);('j crit care', 2);('spontaneous intracerebral hemorrhage', 2);('ann neurol', 2);('suppl', 2);('epilepsy behav', 2);('heart', 2);('c council', 2);('medical research council', 2);('status', 2);('antiepileptic drug withdrawal', 2);('randomized', 2);('valproic', 2);('epilepsy intracerebral h emorrhage update', 1);('md phd sylvain rheims', 1);('md phd laure peter derex', 1);('md phd', 1);('neurology neurological', 1);('claude bernard lyon', 1);('healthcare performance reshape inserm u1290 lyon france', 1);('functional neur', 1);('epileptology hospices civils', 1);('france', 1);('lyon neuroscience', 1);('research center', 1);('inserm u1028 cnrs umr', 1);('lyon france corresponding', 1);('dr laurent derex stroke', 1);('neurology n', 1);('eurological hospital', 1);('hospices', 1);('c ivils', 1);('pinel', 1);('bron', 1);('c edex', 1);('france orcid', 1);('laurentderexchu lyonfr', 1);('dr laure peter derex', 1);('grande', 1);('croix rousse', 1);('lyon france orcid', 1);('laurepeter derexchu lyonfr', 1);('abstract seizures', 1);('common intracerebral h emorrhage', 1);('hours incidence', 1);('subclinical non convulsive seizures', 1);('continuous electroencephalogram', 1);('risk factors f seizures', 1);('cortical location intracerebral h emorrhage presence intraventricular h emorrhage total h emorrhage volume history alcohol abuse', 1);('intracerebral h emorrhage', 1);('sudden blood pressure fl uctuations increase intracranial pressure neuronal injury', 1);('metabolic demand', 1);('recent studies', 1);('days stroke', 1);('prognostic fac tors age baseline h emorrhage volume', 1);('impact seizures prognosis', 1);('th', 1);('available scientific evidence support', 1);('routine use', 1);('seizure medication primary prevention', 1);('patients intracerebral hemorrhage', 1);('tri als', 1);('term settings beneficial n patients intracerebral h emorrhage', 1);('keyw', 1);('intracerebral', 1);('stroke seizu', 1);('epilepsy antiseizure', 1);('declaration funding', 1);('conflicts', 1);('sylvain rheims', 1);('laure peter derex', 1);('principal investigator', 1);('clinicaltrialsgov nct', 1);('availability', 1);('data material', 1);('code', 1);('ethics', 1);('introduction intracerebr', 1);('strokes results death', 1);('severe disability', 1);('disruptive effect neuronal networks hematoma', 1);('high risk', 1);('long term se quelae', 1);('late post stroke epilepsy', 1);('g oal update summarize', 1);('available literature', 1);('epidemiology diagnosis electrophysiological', 1);('seizures epilepsy highlight areas', 1);('terminology seizures', 1);('consequence brain injuries', 1);('time point', 1);('days stroke seizures unprovo', 1);('previously ass', 1);('years terms', 1);('us classi', 1);('recurrent patients', 1);('patient structural lesion', 1);('risk seizures probability seizures', 1);('diagnosis epilepsy', 1);('nition epilepsy', 1);('poststroke epilepsy', 1);('seizures associat', 1);('recurrent seizures', 1);('mechanical effects', 1);('hemorrhage disruptio n cortical networks h ematoma', 1);('properties andor irritation cortex', 1);('products blood metabolism contrast seizures', 1);('attributable subtle cortical', 1);('underlyi ng cerebral', 1);('small vessel disease', 1);('cortical irritat ion hemosiderin depositions gliotic', 1);('inflammatory processes', 1);('epidemiology ich', 1);('ich seizures', 1);('common hemorrhagic ischemic stroke', 1);('comparisons', 1);('difficult different patient populations seizure criteria', 1);('prospective studies', 1);('patients ischemic stroke', 1);('recommendations monitor patients stroke intensive c units', 1);('acute phas e', 1);('studies ic h', 1);('continuous electroencephal ography', 1);('ceeg intensive care unit', 1);('rates subclinical seizures', 1);('electrographic seizures ie seizures', 1);('series ceeg', 1);('seizures occurr', 1);('convulsive seizures', 1);('ceeg electrographic seizures monit', 1);('subpopulation patients', 1);('likely overestimates frequency seizures', 1);('clinical seizure ceeg', 1);('hour ceeg', 1);('proximity cortical surface predictor electrographic seizur es', 1);('likely deep hemorrhages', 1);('clinical subclinical seizures', 1);('hemorrhages increase', 1);('ct', 1);('light studies', 1);('ceeg enhance detection rates seizures', 1);('valuable approach', 1);('valid information', 1);('true incidence rates', 1);('acute seizures', 1);('rate us n retrospective study', 1);('new onset post stroke epilepsy', 1);('cumulative incidence', 1);('survivors devel op', 1);('additional us', 1);('cumulative risk us', 1);('prospective cohort', 1);('consecutive adults', 1);('presence lobar brain microbleeds', 1);('risk us', 1);('potential link', 1);('vasculopathy cerebral amyloid angiopathy us', 1);('functional outc ome', 1);('direct influence outcome', 1);('reflect severity', 1);('risk', 1);('risk factors', 1);('andor us', 1);('cortical subcortical location', 1);('presence intraventricular hemorrhage total hemorrhage volume history alcohol abuse surgical hematoma evacuation', 1);('analysis observational', 1);('helsinki ich', 1);('ich ich', 1);('involves cortex', 1);('differences', 1);('clinical manifestation epilepsy', 1);('adults lead underestimation f epilepsy incidence', 1);('frequent clinical seizure manifestations', 1);('larger ich', 1);('extensive neuronal damage', 1);('risk epileptogenesis us', 1);('subcortical hematoma location', 1);('risk post stroke e pilepsy primary', 1);('long term survivors hypertension', 1);('ichs', 1);('structures hypertensive patients', 1);('early epileptiform activity', 1);('metab olic demand', 1);('secondary brain damage glio tic', 1);('clinical score', 1);('late seizure risk prediction', 1);('points cr', 1);('estimate risk us', 1);('individual patients', 1);('point cortical involvement ge', 1);('years volume', 1);('easy calculate shows', 1);('linear risk increase risk us', 1);('risk scores', 1);('patients risk', 1);('years score', 1);('derivation cohort c statistic', 1);('validation cohort c statistic', 1);('confidence interval', 1);('furth', 1);('er validation cohorts', 1);('ord er', 1);('generalizability authors', 1);('suboptimal scores predictive performance validation cohort raises possibility', 1);('complex biologi cal substrate us', 1);('analysis single centre longitudinal cohort study', 1);('recurrent seizure events patients', 1);('history seizure', 1);('genetic risk factors cerebral', 1);('small vessel disease contrary', 1);('volume severity f neurologic decit onset predictor recurrent seizure risk study', 1);('availability genetic', 1);('apoe', 1);('data presence', 1);('lobar cerebral microbleeds', 1);('ability stratify risk', 1);('electrophysiological', 1);('diagnosis seizures context', 1);('relies clinical symptoms', 1);('andor ceeg', 1);('patterns eeg', 1);('patterns abnormal', 1);('presence focal brain injury', 1);('non', 1);('epileptic patterns consist background abnormalities focal diffuse', 1);('interictal', 1);('epileptic activity', 1);('sporadic epileptiform discharges', 1);('periodic rhythmic patterns', 1);('periodic discharges', 1);('rhythmic delta activity', 1);('rda', 1);('lpds lrda', 1);('gpds grda', 1);('bipds', 1);('ictal', 1);('context ceeg', 1);('discharges type', 1);('frequency 4cs', 1);('patterns time', 1);('patients movements', 1);('interictal patterns', 1);('particular interest', 1);('n ictalinterictal continuum state', 1);('high prevalence non convulsive seizures', 1);('manifestation abnormal neuronal response', 1);('cortical area', 1);('deleterious effect', 1);('detectable radiological brain lesion', 1);('prognosis', 1);('value electrographic ictal interictal patterns prognosis value ictal interictal patterns', 1);('ceeg context', 1);('retrospective studie physiological point view invasive multimodality', 1);('comatose patients', 1);('spontaneous subarachnoid hemorrhage', 1);('intracortical electrodes', 1);('heart rate blood pressure respiratory rate', 1);('type recordings', 1);('high frequency', 1);('brain oxygen level', 1);('sufficient compensatory increase cerebral blood flow', 1);('additional brain damage', 1);('vespa', 1);('non convulsive convulsive seizure', 1);('initial 72h admission', 1);('majority ceeg', 1);('neurologic function brain edema', 1);('midlin e', 1);('rate ceeg', 1);('assens study work', 1);('recent clinical study', 1);('presence epileptiform abnormalities ceeg', 1);('acute ischemic stroke', 1);('poor functional outcome dose', 1);('dependent relationship', 1);('studies retrospective patient evere conditions', 1);('ceeg majority', 1);('poor outcomes', 1);('risk f', 1);('late epilepsy', 1);('context ischemic stroke background activity asymmetry interictal epileptiform discharges', 1);('72h admission', 1);('independent predictor post stroke epilepsy', 1);('epileptic findings electrographic seizures', 1);('acute brain insult', 1);('hr', 1);('ci29', 1);('ci', 1);('neurophysiological biomarkers epileptogenesis processes', 1);('electrographic ictal high risk interictal patterns', 1);('risk epilepsy', 1);('ceeg pat terns presence physiological sleep', 1);('topographical organization electrophysiological activity', 1);('functional mortality outcomes', 1);('recordings', 1);('fact tha high number seizures', 1);('non convulsive seizures patients', 1);('consciousness neurological symptoms', 1);('secondary hemorrhagic lesion', 1);('routine eeg', 1);('record seizures', 1);('interictal discharges whereas ceeg', 1);('number seizures worth', 1);('ceeg sensitivity', 1);('seizures r emain', 1);('blind scalp', 1);('intracortical recordings', 1);('part research protocols comatose patients', 1);('consciousness case', 1);('patients neurointensive care units', 1);('guideline criteria benefit', 1);('clinical neurophysiology', 1);('ociety recommendations ceeg', 1);('order identify non convulsive seizures non convulsive status epilepticus', 1);('acute supratentorial brain injury', 1);('case clinical paroxysmal events', 1);('ceeg use', 1);('inhospital mortality', 1);('spite recommendations ceeg', 1);('stroke units', 1);('neurovascular intensive care settings presence interictal epileptifor discharges', 1);('predictive occurrence ictal patterns ceeg', 1);('select patients ceeg', 1);('48h admission', 1);('new devices dry cap electrode', 1);('widen utilization ceeg stroke patients', 1);('anti', 1);('seizure medication', 1);('ich acute', 1);('phase anagement', 1);('ichrelated ass', 1);('whether', 1);('seizure drugs', 1);('sds', 1);('primary pharmacological prevention seizures', 1);('seizures ich', 1);('sudden blood pressure fluctuations increase intracranial pressure neuronal injury', 1);('outcome series', 1);('cohort study', 1);('acute ischemic hemorrhagic stroke', 1);('patients seizures', 1);('inpatient stay', 1);('year poststroke', 1);('disability discharge', 1);('large study', 1);('early seizures', 1);('hand studies', 1);('association seizures', 1);('early neurologic deterioration mortality', 1);('year patients', 1);('observational studies clinical seizures worsen', 1);('poor prognosis', 1);('common factors outcomes', 1);('large volume', 1);('ich asd', 1);('prophylaxis outcome uncertainty', 1);('relative risks benefits primary prevention seizures', 1);('wide variation rates', 1);('asd ich', 1);('routine use agents', 1);('retrospective study', 1);('academic us centers', 1);('patients primary', 1);('n prophylactic anticonvulsants', 1);('age', 1);('lobar location', 1);('institutes', 1);('stroke scale nihss', 1);('score craniotomy', 1);('prophylactic anticonvulsant initiation', 1);('rophylactic anticonvulsants', 1);('hospital discharge cases months', 1);('years afterward', 1);('toxicity side', 1);('fever liver abnormalities cognitive dysfunction', 1);('specific medication', 1);('phenytoin phenobarbital', 1);('inhibit neural plasticity hinder recovery', 1);('newer asd', 1);('levetiracetam lacosamide bett er', 1);('drug drug interactions', 1);('side effect profiles', 1);('potential neuroprotective effect', 1);('occurrence poststroke epilepsy clinical trial', 1);('treatment brain injury', 1);('stroke prevents mitigates epileptogenesis', 1);('retrospective studies', 1);('treatment epilepsy disability death', 1);('design results studies', 1);('table observational study patients', 1);('early use', 1);('severe disability death', 1);('independent signi cant predictors', 1);('patients cohort', 1);('phenytoin results', 1);('asd interestingly', 1);('months levetiracetam', 1);('multiple factors', 1);('poor outcome prophylactic levetiracetam', 1);('levetiracetam phenytoin patients', 1);('ic h', 1);('cognitive outcomes ischarge', 1);('retrospecti analys cohort patients', 1);('treatment mortality outcome', 1);('results line', 1);('recent retros pective study', 1);('association prophyla ctic', 1);('fun ctional outcome discharge', 1);('yea r', 1);('placebo control', 1);('seizure prevention', 1);('sma sample size n72 use', 1);('use ceeg', 1);('center trial', 1);('immediat e valproic acid', 1);('month placebo nonsignificant', 1);('p04', 1);('recent systematic review meta analys', 1);('studies total', 1);('primary prevention', 1);('adult patients', 1);('neurological function', 1);('evident seizures', 1);('long term', 1);('analysis observational studies unclear risk bias', 1);('moreove', 1);('significant heterogeneity', 1);('studies duration patient', 1);('short time horizons', 1);('important seizures', 1);('high variability definition ea', 1);('late seizures nd studies utilize', 1);('continuous electroen cephalographic', 1);('available data clinical guidelines', 1);('prophylactic antiseizure medication patients', 1);('guidelines management post stroke seizures epilepsy clinicians', 1);('administer primary', 1);('acute phase subgroups patients', 1);('eg cortical involvement', 1);('association guidelines management', 1);('clinical seizures electroencephalogr aphic evidence seizures', 1);('absenc e', 1);('evidence recommendations', 1);('acute symptomatic seizures absence evidence', 1);('long term risk post', 1);('current guidelines indication', 1);('antiseizure medication patients', 1);('risk seizure', 1);('early post', 1);('risk fall injuries aspiration pneum onia', 1);('elderly physician', 1);('treatment choice', 1);('account pharmacokinetics characteristics drug preference', 1);('significant drug drug interactions', 1);('characteristics levetiracetam', 1);('lev', 1);('lcs furthermore', 1);('specific situation repetitive', 1);('status epilepticus occurs', 1);('patients stroke', 1);('addition risk', 1);('ischemic stroke', 1);('issue status epilepticus', 1);('important elderly population mortality agedependent', 1);('cerebrovascular', 1);('acute symptomatic causes status epilepticus', 1);('overall', 1);('principles pharmacological management cluster', 1);('status epilepticus differ', 1);('current guidelines', 1);('line therapy rel', 1);('acute administration benzodiazepines', 1);('patients benzodiazepine refractory status epilepticus levetiracetam sodium valproate fosphenytoin', 1);('difference effic acy safety outcomes', 1);('treatment electrographic epileptic activity treatment indication', 1);('2hz andor', 1);('frequencies andor', 1);('seizure predictive value', 1);('benzodiazepine trial', 1);('useful therapeutic decision', 1);('signs neuronal injury', 1);('secondary excitotoxicity cortical hyperintensities diffusion', 1);('impact curative prophylactic', 1);('uncertain practice patients epileptic findings ceeg', 1);('long time periods', 1);('true epilepsy incidence patients', 1);('management', 1);('secondary prophylaxis', 1);('considerable social consequences', 1);('negative impact quality life prevention seizure recurrence utmost im portance patients', 1);('us recurrence r isk', 1);('patients', 1);('high risk seizure recurrence antiseizure medication', 1);('guidelines state therapy needs', 1);('e cacy', 1);('di erent', 1);('stroke underpo', 1);('trials seizure freedom rates', 1);('months di er levetiracetam carbamazepine', 1);('lamotrigine carbamazepine', 1);('account patient profile', 1);('particular attention enzymatic', 1);('effect potential atherogenic role carbamazepin e', 1);('seizure recurrence risk', 1);('withdrawal patients lesional epilepsy', 1);('conclusion', 1);('future directions', 1);('common complication', 1);('subcortical cortical hemorrhages', 1);('structures majority seizures', 1);('hospital admission', 1);('fre quency impact prognosis clinical seizures', 1);('unclear research', 1);('input ceeg therapeutic mana gement', 1);('large prospective studies', 1);('current', 1);('evidence management post stroke seizures epilepsy', 1);('studies focus preventive use', 1);('risk seizures', 1);('score instance', 1);('trial evaluates potential efficacy levetiracetam', 1);('patients ceeg', 1);('clinicaltrialsg', 1);('nct', 1);('p rospective', 1);('term settings beneficial', 1);('table caption', 1);('asd figure', 1);('box definitions clinical epileptic seizure epilepsy electrographic seizures', 1);('epileptic seizure transient occurrence signs andor symptoms', 1);('due abnormal', 1);('excessive synchronous neuronal activity brain', 1);('disorder brain', 1);('predisposition generate epileptic seizures neurobiological cognitive psychological', 1);('social consequences condition definition epilepsy', 1);('epileptic seizure', 1);('practical', 1);('reflex seizures', 1);('reflex seizure probability seizures', 1);('diagnosis epilepsy syndrome', 1);('seizures rhythmic discharge spike wave pattern', 1);('definite evolution frequency location morphology', 1);('subclinical seizures ie ictal discharges', 1);('clinical signs symptoms', 1);('neurological state patient', 1);('additional seizure symptoms potential symptoms', 1);('epileptic discharge', 1);('routine neurological examination', 1);('classification', 1);('mechanisms seizures epilepsy', 1);('references', 1);('asch cj luitse mj rinkel gj', 1);('van der', 1);('tweel algra klijn cj', 1);('case fatality', 1);('functional outcome intracerebral haemorrhage time', 1);('age sex', 1);('ethnic origin systematic review meta analysis', 1);('lancet ne', 1);('poon mt fonville', 1);('al shahi salman r', 1);('long term prognosis intracerebral haemorrhage systematic review meta analysis', 1);('beghi e dalessandro r beretta consoli crespi v delaj', 1);('gandolfo', 1);('greco g', 1);('neve manfredi mattana', 1);('musolino r provinciali', 1);('santangelo specchio lm zaccara g epistroke g', 1);('acute ymptomatic seizures stroke', 1);('biffi rattani anderson', 1);('ayres gurol em greenberg sm rosand j viswanathan', 1);('seizures intracerebral haemorrhage brain', 1);('pt', 1);('holtkamp beghi e benninger', 1);('kalviainen r rocamora r christensen h', 1);('stroke organisation', 1);('guidelines management post stroke seizures epilepsy', 1);('beghi e carpio forsgren', 1);('hesdorffer dc malmgren k sander jw tomson hauser wa', 1);('recommendation', 1);('acute symptomatic seizure', 1);('fisher rs acevedo', 1);('arzimanoglou bogacz', 1);('jh elger ce engel j jr forsgren', 1);('french ja', 1);('glynn hesdorffer dc lee bi mathern gw moshe sl perucca e scheffer ie tomson watanabe wiebe', 1);('official port', 1);('practical clinical definition epilepsy', 1);('doria jw forgacs pb', 1);('incidence implications management seizures following ischemic hemorrhagic stroke curr neurol neurosci rep', 1);('klein p dingledine r aronica e bernard', 1);('blumcke boison brodie mj brooks kayal ar engel j jr forcelli pa hirsch lj kaminski rm klitgaard h kobow k lowenstein dh pearl pl pitkanen puhakka n rog', 1);('schmidt sillanpaa sloviter rs steinhauser', 1);('vezzani walker mc loscher', 1);('commonalities', 1);('epileptogenic processes', 1);('different acute brain insults', 1);('vespa pm ophelan k shah mirabelli j starkman kidwell', 1);('saver j nuwer mr frazee jg mcarthur da martin na', 1);('acute', 1);('seizures intracerebral hemorrhage factor progressive midline', 1);('doi1012120 1wnl000006331647591b4', 1);('szaflarski jp rackley ay kleindorfer khoury j woo miller r alwell k broderick jp kissela bm', 1);('acute phase stroke population', 1);('de herdt v dumont', 1);('henon h derambure p vonck k leys cordonnier', 1);('seizures intracerebral hemorrhage incidence', 1);('factors outcome', 1);('zk england tj mistri ak woodhouse lj cala', 1);('dineen r ozturk beridze collins r bath pm sprigg n', 1);('early seizures intracerebral haemorrhage effect tranexamic acid', 1);('el annegers jf hauser wa obrien pc whisnant jp', 1);('population', 1);('study seizure disorders cerebral infarction', 1);('bladin cf alexandrov av bellavance bornstein n chambers', 1);('cote r lebrun', 1);('pirisi norris jw', 1);('prospective multicenter study', 1);('qureshi ai tuhrim broderick jp batjer hh hondo h hanley df', 1);('spontaneous', 1);('n engl j med', 1);('neshige kuriyama yoshimoto takeshima himeno takamatsu k sato ota', 1);('intracerebral hemorrhage risk factor recurrence efficacy antiepileptic drug', 1);('j neurol sci', 1);('gilmore ej maciel cb hirsch lj sheth kn', 1);('review utility prophylactic anticonvulsant', 1);('critically ill patients intracerebral hemorrhage stroke', 1);('naidech beaumont j muldoon k liotta em maas mb potts mb jahromi bs cella prabhakaran holl jl', 1);('prophylactic seizure medication', 1);('related quality', 1);('intracerebral hemorrhage crit care med', 1);('claassen j jette n chum', 1);('r schmidt choi h jirsch j frontera', 1);('connolly es emerson rg mayer sa hirsc', 1);('lj', 1);('periodic discharges intracerebral hemorrhage', 1);('madzar kuramatsu jb gollwitzer lucking h kloska sp hamer hm kohrmann huttner hb', 1);('long term survivors', 1);('patients incidence risk factors impact', 1);('lahti saloheimo p huhtakangas j salminen h juvela bode mk hillbom tetri', 1);('poststroke', 1);('long term survivors primary intracerebral hemorrhage', 1);('rossi', 1);('de herdt v dequatre ponchelle n henon h leys cordonnier', 1);('seizures intracerebral hemorrhages', 1);('haapaniemi e strbian rossi', 1);('putaala j sipi mustanoja sairanen curtze satopaa j roi', 1);('r kaste cordonnier', 1);('tatlisumak meretoja', 1);('late seizures intracerebral hemorrhage', 1);('faught e peters bartolucci moore', 1);('miller pc', 1);('primary intracerebral hemorrhage', 1);('garrett mc komotar rj starke rm merkow mb otten ml connolly es', 1);('seizure onset intracerebral hemorrhage role', 1);('long term antiepileptic therapy', 1);('srinivasan shin h chou sh pennell pb dworetzky ba lee jw', 1);('antiepileptic drugs patients', 1);('spontaneous intracerebral hemor rhages', 1);('passero rocchi r rossi ulivelli vatti g', 1);('spontaneous supratentorial intracerebral hemorrhage', 1);('yang tm lin wc chang wn ho jt wang hc tsai', 1);('shih yt lu ch', 1);('outcome seizures', 1);('j neurosurg', 1);('hirsch lj laroc sm gaspard n gerard e svoronos herman st mani r arif h jette n minazad kerrigan jf vespa p hantus claassen j', 1);('gb e kaplan pw nuwer mr fountain nb drislane fw', 1);('clinical neurophysiology societys standardized critical care eeg terminology', 1);('snodgrass sm tsuburaya k ajmone marsan', 1);('epileptiform discharges relationship tatus epilepticus', 1);('pohlmann eden', 1);('hoch db cochius ji chiappa kh', 1);('periodic', 1);('epileptiform discharges', 1);('critical review', 1);('lin', 1);('drislane fw', 1);('lateralized periodic discharges literature review j clin neurophysiol', 1);('sainju rk manganas ln gilmore ej petroff oa rampal n hirsch', 1);('j gaspard n', 1);('clinical correlates prognostic significance lateralized periodic discharges patients', 1);('acute progressive', 1);('injury case', 1);('j perotte albers kleinberg schmidt jm tu', 1);('badjatia n lantigua h hirsch lj mayer sa connolly es hripcsak g', 1);('nonconvulsive', 1);('seizures subarachnoid hemorrhage', 1);('multimodal', 1);('detection outcomes', 1);('doi1 01002ana23859', 1);('witsch j frey hp schmidt jm velazquez falo cm reznik roh agarwal', 1);('connolly es claassen j', 1);('electroencephalographic periodic discharges frequency dependent', 1);('tissue hypoxia acute', 1);('injury jam neurol', 1);('tabaeizadeh aboul nour h shoukat sun h jin j javed', 1);('kassa edhi bordbar e gallagher j moura vj ghanta shao yp cole aj rosenthal es westover mb zafar sf', 1);('burden epileptiform activity predicts discharge neurologic outcomes severe acute ischemic stroke neurocrit care', 1);('bentes', 1);('martins h peralta ar morgado', 1);('casimiro', 1);('franco ac fonseca ac geraldes r canh', 1);('p pinho emt paiva ferro jm', 1);('early eeg', 1);('predicts poststroke epilepsy', 1);('punia v bena j krishnan', 1);('newey', 1);('hantus', 1);('periodic discharges c ontinuous electroencephalographic', 1);('punia v fitzgerald z zhang x huynh h bena j morrison newey cr hantus', 1);('electroencephalographic', 1);('biomarkers epilepsy development patient', 1);('acute brain injury', 1);('parallel cohort study', 1);('ann clin transl neurol', 1);('engel j jr pitkanen loeb', 1);('dudek fe bertram eh', 1);('cole aj moshe sl wiebe jensen fe mody nehlig vezzani', 1);('purandare ehlert vaitkevicius h dworetzky ba lee jw', 1);('role ceeg predictor patient outcome survival patients intraparenchymal hemorr hages', 1);('marcellino cr lapalme remis rabinstein aa van gompel jj worrell', 1);('payne et hocker', 1);('cortical', 1);('surface intracranial electrodes identify', 1);('relevant seizures', 1);('sc alp', 1);('traumatic intracranial hemorrhage', 1);('epileptic disord', 1);('claassen j taccone fs horn p holtkamp stocchetti n oddo neurointensive care', 1);('european society', 1);('intensive care', 1);('recommendations', 1);('patients consensus statement neurointensive care section', 1);('esicm intensive care med', 1);('ghasemi azeem mu muehlschlegel ch', 1);('u f', 1);('henninger n', 1);('prescription', 1);('patients intracranial hemorrhage', 1);('neurointensive care unit', 1);('herman st abend ns bleck tp chapman ke dr', 1);('fw emerson rg gerard ee hahn', 1);('husain kaplan pw laroche sm nuwer mr quigg riviello jj schmitt', 1);('simmons la tsuchida tn hirsch lj critical care continuous eegtfotacns', 1);('consensus', 1);('adults children part indications', 1);('bermeo ovalle', 1);('bringing eeg', 1);('neurocritical care epilepsy curr', 1);('koren j herta j draschtak potzl g pirker furbass', 1);('hartmann kluge baumgartner', 1);('prediction', 1);('patterns seizures', 1);('early epileptiform discharges', 1);('doerrfuss ji kilic ahmadi weber je holtkamp', 1);('predictive', 1);('measurements seizures epilepsy stroke', 1);('dry cap electrode', 1);('design proof concept', 1);('pt b106486', 1);('morgenstern lb hemphill jc', 1);('anderson', 1);('becker k broderick jp connolly es jr greenberg sm huang jn macdonald rl messe sr mitchell ph selim tamargo rj', 1);('cardiovascular n', 1);('guidelines', 1);('spontaneous intracerebral hemorrhage guideline healthcare professionals', 1);('hemphill jc', 1);('greenberg sm anderson cs becker k bendok br cushman fung gl goldstein jn macdonald rl mitchell ph scott pa selim mh woo', 1);('c stroke n cou', 1);('guidelines management spontaneous intracerebral hemorrhage guideline healthcare professionals', 1);('burneo jg fang j saposnik g investigators registry', 1);('stroke n', 1);('impact', 1);('seizures morbidity mortality stroke', 1);('canadian multi centre cohort study', 1);('eur j neurol', 1);('leira r davalos silva gil peralta tejada j garcia castillo j stroke project cdgotsns', 1);('neurologic deterioration intracerebral hemorrhage predictors', 1);('doi10121201w nl000013320481153ac', 1);('kilpatrick cj davis sm tress bm rossiter sc hopper jl vandendriesen ml', 1);('acute stroke', 1);('burn j dennis bamford j sanderco', 1);('p wade warlow', 1);('oxfordshire', 1);('stroke project bmj', 1);('labovitz dl hauser wa sacco rl', 1);('prevalence', 1);('early seizure status epilepticus', 1);('mackey j blatsioris ad moser eas carter rjl saha', 1);('stevenson hulin al oneill dp cohen gadol aa leipzig tj williams ls', 1);('prophylactic anticon', 1);('intracerebral hemorrhage neurocrit care', 1);('troisi e paolucci silvestrini matteis vernieri', 1);('grasso mg caltagirone', 1);('prognostic', 1);('factors stroke rehabilitation', 1);('possible rol e pharmacological treatment', 1);('acta neurol scand', 1);('doi101034j1600 040420021o052x', 1);('shetty ak', 1);('prospects', 1);('levetiracetam neuroprotective drug status epilepticus traumatic brain injury stroke', 1);('front neurol', 1);('temkin nr', 1);('antiepileptogenesis', 1);('seizure prevention trials antiepileptic drugs meta analysis', 1);('doi101046j1528 1157200128900x', 1);('marson jacoby j', 1);('kim', 1);('gamble', 1);('chadwick', 1);('msg', 1);('immediate', 1);('antiepileptic drug treatment', 1);('epilepsy single seizures', 1);('gilad r boaz dabby r sadeh lampl', 1);('post intracerebral hemorrhage seizures', 1);('epileptic treatment', 1);('messe sr sansing lh cucchiara bl herman st lyden pd kasner', 1);('se investigators c', 1);('prophylactic', 1);('antiepileptic drug use', 1);('ich neurocrit care', 1);('naidech garg rk liebling levasseur k macken mp schu', 1);('su batjer hh', 1);('anticonvulsant', 1);('outcomes intracerebral hemorrhage', 1);('reddig rt nixdorf ke jensen mb', 1);('prophylactic use antiepileptic drug intracerebral hemorrhage', 1);('clin neurol neurosurg', 1);('sheth kn martini sr moomaw cj koch elkind ms sung g kittner sj frankel rosand j langefeld', 1);('comeau waddy sp osborne j woo investigators e', 1);('prophylactic antiepileptic drug', 1);('outcome ethnicracial variations intracerebral hemorrhage', 1);('taylor heinrichs rj janzen jm ehtisham', 1);('cognitive outcome patients intracranial hemorrhage', 1);('szaflarski jp sangha ks lindsell cj shutter la', 1);('comparative trial intravenous levetiracetam versus phenytoin seizure prophylaxis', 1);('battey tw falcone gj ayres schwab k viswanathan mcnamara ka dipucchio zy greenberg sm sheth kn goldstein jn rosand j', 1);('confounding', 1);('indication retrospective studies intracerebral hemorrhage antiepileptic treatment mortality', 1);('angriman', 1);('tirupakuzhi vijayaraghavan bk dragoi', 1);('lopez soto', 1);('chapman scales dc', 1);('antiepileptic drugs prevent seizures spontaneous intracerebral hemorrhage stroke', 1);('steiner al shahi salman r beer r christensen h cord', 1);('onnier c', 1);('csiba', 1);('forsting harnof klijn cj krieger mendelow ad molina', 1);('montaner j overgaard k petersson j roine ro schmutzhard e schwerdtfeger k stapf', 1);('tatlisumak thomas bm toni unterberg wagner', 1);('guidelines management', 1);('int j stroke', 1);('haut sr', 1);('clusters characteristics treatment', 1);('curr opin neurol', 1);('leppik ie', 1);('rohracher reiter dp brigo', 1);('kalss g thomschewski novak h zerbs dobesberger j akhundova hofler j kuchukhidze g leitinger trinka e', 1);('elderly retrospective study', 1);('glauser shinnar gloss alldredge', 1);('arya r bainbridge j', 1);('bar e', 1);('bleck dodson garrity', 1);('jagoda lowenstein pellock j riviello j sloan e treiman dm', 1);('evidence based guideline', 1);('convulsive status epilepticus', 1);('adults', 1);('guideline', 1);('epi', 1);('lepsy society', 1);('epilepsy curr', 1);('chamberlain jm kapur j shinnar', 1);('j holsti babcock', 1);('rogers barsan', 1);('cloyd j lowenstein bleck tp conwit r meinzer', 1);('cock h fountain nb underwood e connor jt silbergleit r neurological emergencies', 1);('pediatric emergency care applied', 1);('network', 1);('efficacy', 1);('levetiracetam fosphenytoin valproate', 1);('status epilepticus age group', 1);('esett', 1);('blind responsive adaptive', 1);('bauerschmidt rubinos', 1);('claassen j', 1);('approach', 1);('periodic discharges j clin neurophysiol', 1);('lansberg mg obrien mw norbash moseley morrell albers gw', 1);('partial status epilepticus', 1);('canas n breia p soares p saraiva p calado jordao', 1);('vale j', 1);('electroclinical imagiological spectrum', 1);('long term outcome transient periictal', 1);('balami js buchan', 1);('complications', 1);('intracer ebral haemorrhage', 1);('lancet neurol', 1);('hesdorffer dc benn ek cascino gd hauser wa', 1);('acute symptomatic seizure epilepsy', 1);('mortality', 1);('risk recurrent seizure', 1);('doi101111j1528 1167200801945x', 1);('berger ar lipton rb lesser ml lantos g portenoy rk', 1);('intracerebral hemorrhage implications therapy', 1);('sung cy chu ns', 1);('seizures intracerebral haemorrhage', 1);('consoli bosco postorino p galati', 1);('plastino perticoni gf ottonello', 1);('passarella', 1);('ricci neri g toni', 1);('versus carbamazepine patients', 1);('poststroke seizures', 1);('open label study', 1);('epic project cerebrovasc dis', 1);('gilad r sadeh rapoport dab r boaz lampl', 1);('monotherapy', 1);('lamotrigine versus carbamazepine patients poststroke seizure', 1);('clin neuropharmacol', 1);('mintzer skidmore ct abidin cj morales mc chervoneva capuzzi dm sperling mr', 1);('effects', 1);('antiepileptic drugs lipids homocysteine c reactive protein', 1);('randomised', 1);('study antiep ileptic drug withdrawal patients remission', 1);('lossius mi hessen e mowinckel p stavem k erikssen j gulbrandsen p gjerstad', 1);('consequences', 1);('blind study kershus', 1);('doi101111j1528 1167200701323x', 1);('fisher rs', 1);('emde boas', 1);('blume', 1);('elger', 1);('genton p lee p engel j jr', 1);('seizures epilepsy definitions', 1);('international bureau', 1);('epilepsy ibe epilepsia', 1);('doi101111j0013 9580200566104x', 1);('claassen j mayer sa kowalski rg emerson rg hirsch lj', 1);('detection', 1);('year design total sample size', 1);('asds outcome mess', 1);('disability death', 1);('naidech', 1);('phenytoin levetiracetam phenytoin', 1);('szaflarski', 1);('comparative trial', 1);('phenytoin levetiracetam leveti', 1);('gilad', 1);('reddig', 1);('hospital death', 1);('taylor', 1);('cognitive outcome', 1);('sheth', 1);('mackey', 1);